2015 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




CMS Proposed Rule Would Modify "Two-Midnight" Policy

July 2, 2015 -- The Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule that would revise a number of provisions for calendar year 2016, including&nb…

CMS’ Open Payments Posts Full Year of 2014 Financial Data

June 30, 2015 -- The US Centers for Medicare & Medicaid Services (CMS) published 2014 Open Payments data about transfers of value by drug and medical device makers to heal…

FDA Clears Hansen Medical’s Magellan 10-F Robotic Catheter

July 1, 2015 -- Hansen Medical, Inc. announced that it received US Food and Drug Administration (FDA) 510(k) clearance for its Magellan 10-F robotic catheter for use in the pe…

ABIM Will Discontinue Requirement for Maintaining Underlying Board Certification for Interventional Cardiology and 14 Other Subspecialties

July 1, 2015 -- The American Board of Internal Medicine (ABIM) announced that the ABIM Council has unanimously approved policy changes so that diplomates certified in nine sub…

MIMICS-2 Study Begins for Veryan Medical’s BioMimics 3D Stent System

July 1, 2015 -- Veryan Medical Ltd. announced the commencement of the MIMICS-2 study of the company’s BioMimics 3D stent system, which features a nitinol stent with a th…

Lombard Medical Launches the Aorfix Plus Endovascular Stent Graft

June 30, 2015 -- Lombard Medical, Inc. announced the launch of the Aorfix Plus endovascular stent graft in the United States with the successful completion of the first clinic…

Daiichi Sankyo’s Edoxaban Approved in Europe

June 30, 2015 -- Daiichi Sankyo Company, Limited announced last week that the European Commission has granted authorization for edoxaban, which will be marketed as L…

Click here for more News coverage

Current Supplement

Sponsored by GORE & ASSOCIATES

Complete Coverage for Complex In-Stent Restenosis

Data, comparative analysis, and consensus on the role of the GORE® VIABAHN® Endoprosthesis.

physician counsel

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Open Payments Errors Could Put Physicians in a Bad Light

As the Open Payments website becomes more user-friendly, physicians must ensure their disclosures are accurate, or risk misinterpretation.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




Vascular Market Price  Change
Abbott Laboratories $49.23  -0.59%
AstraZeneca PLC $65.29  1.01%
Boston Scientific Corporation $17.50  -1.66%
BTG plc $686.00  6.94%
Cardiovascular Systems Inc. $26.01  1.21%
CR Bard Inc. $170.93  -1.06%
Edwards Lifesciences Corp. $141.69  -1.33%
Endologix Inc. $14.74  -0.61%
Hansen Medical, Inc. $0.91  5.83%
Vascular Market Price  Change
Johnson and Johnson $98.39  -0.08%
Lombard Medical, Inc. $4.27  3.14%
Medtronic, Inc. $73.67  -0.55%
Merit Medical Systems, Inc. $21.27  -0.65%
St. Jude Medical Inc. $72.44  -1.62%
The Medicines Company $30.46  7.48%
The Spectranetics Corporation $21.34  -3.83%
TriVascular Technologies, Inc. $5.40  -0.92%
Vascular Solutions Inc. $34.13  -1.91%


Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media